Fibromyalgia: A Functional Medicine Perspective
Fibromyalgia isn't 'just in your head.' Learn the root causes — central sensitization, gut dysfunction, nutrient deficiencies — and evidence-based treatments.
Dr. Jake Dalbec, DC · Chiropractor · · 10 min read
Reviewed by Dr. Elicia Kennedy, MD
Key Takeaways
- ✓Fibromyalgia is a central sensitization disorder — the nervous system amplifies pain signals, not an imaginary condition
- ✓Small intestinal bacterial overgrowth (SIBO) is found in up to 100% of fibromyalgia patients in some studies and may be a treatable root cause
- ✓Magnesium, vitamin D, and CoQ10 deficiencies are significantly more common in fibromyalgia patients and correction can reduce symptoms
- ✓Low-dose naltrexone (LDN) at 1.5-4.5mg has shown 30% pain reduction in fibromyalgia trials with minimal side effects
You ache everywhere. The fatigue is crushing. Brain fog makes simple tasks feel impossible. You've seen multiple doctors. Some believed you. Many didn't. You may have been told it's stress, depression, or — worst of all — that it's all in your head.
It's not. Fibromyalgia is a recognized central sensitization syndrome affecting 2-4% of the population, predominantly women. Brain imaging, spinal fluid analysis, and genetic studies confirm it as a real neurobiological condition. The problem isn't that fibromyalgia is imaginary — it's that conventional medicine has limited tools to address its root causes.
What's Actually Happening in Your Nervous System
In fibromyalgia, the central nervous system's pain processing volume is turned up. Functional MRI studies show that fibromyalgia patients respond to mild pressure with the same brain activation patterns that healthy controls show only with intense pain (Gracely et al., 2002).
Spinal fluid studies reveal substance P (a pain neurotransmitter) levels 3x higher than normal, elevated glutamate (excitatory neurotransmitter), and reduced serotonin and norepinephrine (inhibitory pain modulators). The result: pain amplification plus reduced pain inhibition — a double hit (Bradley, 2009).
Glial cells (microglia and astrocytes) in the brain and spinal cord are chronically activated, releasing inflammatory cytokines that maintain sensitization. Recent PET scan studies confirmed neuroinflammation in multiple brain regions of fibromyalgia patients (Albrecht et al., 2019).
The Gut Connection
One of the most striking findings in fibromyalgia research is its association with gut dysfunction. A study by Pimentel et al. found that 100% of fibromyalgia patients tested positive for SIBO (small intestinal bacterial overgrowth) using lactulose breath testing (Pimentel et al., 2004). While this finding hasn't been replicated at 100%, subsequent studies consistently show SIBO rates of 50-80% in fibromyalgia populations.
The mechanism: bacterial overgrowth in the small intestine produces lipopolysaccharides (LPS) that trigger systemic inflammation through the gut-brain axis. LPS activates microglia and maintains central sensitization. Treating SIBO with targeted antibiotics or herbal antimicrobials has been shown to reduce fibromyalgia symptoms when the overgrowth is present.
Gut permeability ("leaky gut") is another frequent finding. When the intestinal barrier is compromised, food proteins and bacterial products enter circulation, activating the immune system and maintaining the inflammatory state that drives pain amplification.
Nutrient Deficiencies
Several nutrient deficiencies are significantly more common in fibromyalgia and may contribute to symptom maintenance:
Magnesium: Studies show lower red blood cell magnesium levels in fibromyalgia patients. Supplementation with magnesium citrate (300mg) plus malic acid reduced pain and tenderness scores significantly over 8 weeks in a double-blind trial (Russell et al., 1995).
Vitamin D: Deficiency (below 20 ng/mL) is found in 40-70% of fibromyalgia patients. A meta-analysis found vitamin D supplementation produced a clinically meaningful reduction in pain scores (Yong et al., 2017). Target: 40-60 ng/mL.
CoQ10: Fibromyalgia patients show lower CoQ10 levels, particularly in skin biopsies. Supplementation with 300mg/day reduced pain, fatigue, and morning tiredness in a randomized trial.
B12 and folate: Elevated homocysteine and spinal fluid markers suggest impaired methylation in subsets of fibromyalgia patients.
Promising Treatments
Low-dose naltrexone (LDN): At 1.5-4.5mg daily (far below the 50mg dose used for addiction), naltrexone blocks microglial activation and modulates the endorphin system. A Stanford pilot study found LDN reduced fibromyalgia pain by 30% with minimal side effects (Younger et al., 2013). It's off-label, inexpensive, and increasingly prescribed by functional medicine practitioners.
Aquatic exercise: Exercising in warm water (33-36°C) reduces pain perception during activity and builds exercise tolerance. A Cochrane review found aquatic exercise improved pain, physical function, and wellbeing in fibromyalgia (Bidonde et al., 2014).
Mindfulness-based stress reduction (MBSR): An 8-week MBSR program reduced fibromyalgia symptom severity, with benefits persisting at 6-month follow-up.
When to See a Practitioner
If you've been diagnosed with fibromyalgia and haven't explored root causes, seek a functional medicine practitioner who will evaluate: gut health (SIBO breath test, stool analysis), nutrient status (magnesium RBC, vitamin D, B12, iron), hormonal function (thyroid, cortisol, sex hormones), sleep architecture (sleep study if needed), and inflammatory markers. Many patients who were told "nothing can be done" find significant relief when these underlying factors are systematically addressed.